Brookfield Infrastructure To Invest Up To $15 Bln In Intel's Production Expansion Project

Brookfield Infrastructure Partners L.P. (BIP) said on Tuesday that it has signed a deal with Intel Corp. (INTC) to invest up to $15 billion for a 49 percent stake in Intel's multi-year production expansion project at its Ocotillo campus in Chandler, Arizona. Intel said the joint investment in the semiconductor co-Investment program will be up to $30 billion.

The transaction, expected to be completed by the end of 2022, will allow Intel to own the remaining 51 percent stake in the project and operating control of the two new leading-edge chip factories in Chandler. The project is part of Intel's integrated device manufacturing or IDM 2.0.

Further, Brookfield has also secured binding non-recourse financing to fund a significant portion of its capital investment in the arrangement with Intel.

The Toronto-based global infrastructure company expects that the equity portion for this investment will be phased over the duration of the construction period and is anticipated to be $500 million to $750 million in aggregate.

Funding is expected to be sourced primarily from retained operating cash flow and proceeds from its capital recycling program.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hormel Foods Corp. (HRL) said, in the fourth quarter, the company delivered earnings per share comparable with record results last year, which included an additional week of sales. Pretax earnings were $357 million, up 1% from a year ago. Organic net sales were up 2%, excluding the impact of an additional... Over the Thanksgiving holiday weekend, from Thanksgiving Day to Cyber Monday, around 196.7 million Americans shopped in stores and online, higher than the previous year, according to the National Retail Federation or NRF. Black Friday continued to be the most favored day for in-store as well as online shopping during the five-day holiday period. Lenoir, North Carolina -based Exela Pharma Sciences, LLC has expanded its recall of Sodium Bicarbonate Injection due to vial breakage to include more lots, the U.S. Food and Drug Administration said. The product is used for treatment of metabolic acidosis and is packaged in a 50 mL glass vial, 20 vials per carton.
Follow RTT